Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrevTel: Telmisartan for Prevention of Paclitaxel-Induced Neuropathic Pain
NCT05322889Phase 2Completed
- Sponsor
- Dr. Frank Behrens
- Start
- Apr 2020
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of telmisartan in peripheral neuropathy, sponsored by Dr. Frank Behrens. Started Apr 2020; status: completed.
02
Drugs
telmisartan
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT05322889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05322889.